BRAINED Study
Start date:April 2018 End date:
August 2020 Co-ordinated by:
Neurosurgery Department, Western General Hospital, Edinburgh Main trial site:
RIE & Western General Hospital, Edinburgh
Blood samples will be assessed using infrared spectroscopy as part of a project looking at tumour biomarkers to ascertain whether people most at risk of having a brain tumour can be correctly identified.
This is a tissue governance project aiming to recruit 600 participants in order to inform a larger trial.
Chief Investigator
Mr Paul Brennan
Consultant Neurosurgeon
Local PI
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Research Team
Rachel O'Brien
Lead Research Nurse
Clare Moceivei
Research Nurse- Bank Staff
Allan MacRaild
Stroke Lead Research Nurse
Jessica Teasdale
Senior Research Nurse - Stroke/Neurosurgery
Michelle Coakley
Senior Research Nurse - Stroke/Neurosurgery
More EMERGE Trials
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
NOVEL Study
Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions
DASH Trial
DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.